Mersana Therapeutics Inc (NAS:MRSN)
$ 2.37 0.07 (3.04%) Market Cap: 292.77 Mil Enterprise Value: 160.46 Mil PE Ratio: 0 PB Ratio: 237.00 GF Score: 29/100

Q1 2020 Mersana Therapeutics Inc Earnings Call Transcript

May 08, 2020 / 12:00PM GMT
Release Date Price: $9.81 (-2.10%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to the Mersana First Quarter 2020 Earnings Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your speaker today, Sarah Carmody, Executive Director, Investor Relations and Corporate Communications. Thank you. Please go ahead, ma'am.

Sarah Carmody
Mersana Therapeutics, Inc. - Executive Director of IR & Corporate Communications

Good morning. Welcome to Mersana's First Quarter 2020 Conference Call.

We issued a press release earlier this morning reviewing our first quarter 2020 results and business updates, which will be covered on this call. A replay of today's call will be available on the Investors & Media section of our website. After our prepared remarks, we will open the call for Q&A.

Before we begin, I'd like to mention that our call will contain forward-looking statements within the meaning of federal securities laws. These are not statements of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot